All posts tagged
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
Stories We Didn’t Cover: Next Human CRISPR Trials by Intellia?
UPDATE: No Clear Winner in the CRISPR Patent Battle
How much of a Gamble is Investing in CRISPR?
CRISPR Therapeutics applies to go Public in another Massive IPO
Top 5 Things you need to know from outside the EU this week: (Truvada, Nanoclews, CRISPR-Cas9)
Labiotech UG, All Rights Reserved -
Send this to a friend